IDEXX Laboratories, Inc.
IDXX
$491.70
$1.720.35%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 242.68M | 216.15M | 232.84M | 203.30M | 235.58M |
| Total Depreciation and Amortization | 34.06M | 33.71M | 34.13M | 32.19M | 29.90M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21.91M | 20.91M | 10.47M | -1.46M | 14.52M |
| Change in Net Operating Assets | -60.69M | -8.74M | -57.37M | 14.28M | -81.42M |
| Cash from Operations | 237.96M | 262.03M | 220.08M | 248.31M | 198.59M |
| Capital Expenditure | -30.03M | -29.26M | -28.09M | -33.31M | -30.27M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | 306.00K | 0.00 | -77.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 416.00K | -10.59M | 415.00K | 398.00K | 329.00K |
| Cash from Investing | -29.61M | -39.84M | -27.37M | -32.91M | -106.94M |
| Total Debt Issued | 69.50M | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | -75.00M | -- | -- |
| Issuance of Common Stock | 7.19M | 13.26M | 5.00M | 5.36M | 20.88M |
| Repurchase of Common Stock | -407.01M | -246.04M | -220.98M | -215.60M | -164.95M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -330.32M | -232.78M | -290.98M | -210.24M | -144.07M |
| Foreign Exchange rate Adjustments | -2.33M | -9.77M | 5.31M | -1.01M | -4.07M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -124.30M | -20.37M | -92.95M | 4.16M | -56.50M |